When to start antiretroviral therapy: the need for an evidence base during early HIV infection

BACKGROUND: Strategies for use of antiretroviral therapy (ART) have traditionally focused on providing treatment to persons who stand to benefit immediately from initiating the therapy. There is global consensus that any HIV+ person with CD4 counts less than 350 cells/μl should initiate ART. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundgren, Jens D, Babiker, Abdel G, Gordin, Fred M, Borges, Álvaro H, Neaton, James D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682886/
https://www.ncbi.nlm.nih.gov/pubmed/23767777
http://dx.doi.org/10.1186/1741-7015-11-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682886/
https://www.ncbi.nlm.nih.gov/pubmed/23767777
http://dx.doi.org/10.1186/1741-7015-11-148

Ejemplares similares